Industries > Pharma > Stents Market Report 2020-2030

Stents Market Report 2020-2030

Forecasts by Product (Peripheral, Coronary), by Peripheral Stents Type (Iliac Stents, Femoral-Popliteal Stents, Renal Stents, Carotid Stents, Neurovascular Stents, Gastrointestinal), by Coronary Stents Type (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents), by Material (Metal, Polymers, Biomaterials), by End-user (Hospitals, Cardiac Centers), by Type (Balloon-Expandable Stents, Self-Expandable Stents). Plus Analysis of Leading Companies and Countries

PUBLISHED: 23 July 2020
PAGES: 762
PRODUCT CODE: PHA0806
SUBMARKET: Medical Devices

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0806 Categories: , Tag:

According to Visiongain analysis, the global stents market was valued at US $xx billion in 2019 and is projected to reach a market value of US $xx billion by 2030. The global market is expected to grow at a CAGR of xx% during the forecast period 2020-2030. The market is estimated to grow at a CAGR of xx% in the first half period 2020-2025 and is projected to grow at a CAGR of xx% in the other half period 2025-2030.

To access the data contained in this document please email contactus@visiongain.com

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Rising Prevalence of Diseases Worldwide
The high and growing prevalence and incidence of diseases, especially coronary and peripheral artery diseases (PAD), which account for the majority of stents use, is increasing and stimulating the demand for stents. In Europe, the U.S. and Japan, cardiovascular diseases (CVD) are a leading cause of death. For instance, in Japan, one-third of all deaths are attributed to heart diseases. In the U.S., CVD accounts for about 25% of total deaths.

Continuous Product and Technology Developments
Continuous significant product/technology advancements and developments have been made in the stents market in the past decade, and these advancements have been a major growth driver of this market. Manufacturers are continuously working on improving and developing products/technology to overcome key issues with stent implantation such as restenosis and thrombosis. The stents market has not only introduced a new generation of stents over time but has also improved technical specifications and developed wider application areas for stents. The slumping stents market is improving due to innovation, the continuous influx of new products and technologies that can compete with ever-increasing competition from alternative technologies and substitutes worldwide, and better health care outcomes.

Decline In Average Selling Prices
Increasing competition is continuously making the stents market more cost-sensitive with time. Also, current global economic conditions along with health care reforms are adding to the competitive pressure and changing market dynamics, leading to the continuous decline in average selling prices of stents such as bare-metal stents and drug-eluting stents, primarily in the cardiology space (which holds a majority share of the global stents market).

Average prices paid by hospitals for stents (considering the average for stents by different manufacturers and type of stents) has declined by approximately 20% to 30% over the past five years to seven years as revealed during interviews with some hospitals and physicians. These prices are expected to decline further for some stents, such as bare-metal stents and drug-eluting stents (especially in the cardiology space) as the market experiences increased adoption (compared to the current situation) of the newest generation of stents, such as biodegradable/bioabsorbable stents.

The comprehensive report offers market estimation and forecast for the period ranging from 2020 – 2030 for leading national markets and the rest of the world. Moreover, the report contains dedicated leading companies covering leading companies in the field of Stents Market. The report provides market size estimations and forecasts for below-mentioned segments

By Product Type
• Peripheral Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Coronary Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

By Peripheral Stents Type
• Iliac Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Femoral-Popliteal Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Renal Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Carotid Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Neurovascular Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Gastrointestinal Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Others Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

By Coronary Stents
• Bare Metal Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Drug Eluting Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Bioresorbable Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Others Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

By Material
• Metal Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Polymer Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Biomaterial Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Other Materials Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

By End-User
• Hospitals Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Cardiac Centers Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Other End–User Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

By Type
• Balloon-Expandable Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Self-Expandable Stents Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Other Types Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

By Region
• North America Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Europe Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Asia-Pacific Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Middle East & Africa Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)
• Latin America Market Size Forecast 2020-2030
– (V-shaped, U-shaped, W-shaped, L-shaped Recovery Scenario Analysis included)

Stents Market Report 2020-2030

Leading companies
• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic PLC
• Terumo Corp
• Stentys SA
• MicroPort Scientific Corporation
• Becton Dickinson and Co
• InspireMD Inc
• Olympus Corp
• Taewoong Co., Ltd.

Visiongain believes that the stents market will register strong growth. This report examines in detail the market by product type, peripheral stents, coronary stents, type, material, end-user, by region, and as a whole, providing the reader with a thorough overview of the market to help identify key growth areas and business opportunities to exploit. This is where Visiongain adds value.

The Global Stents Market 2020-2030 report will be of value to anyone who wants to better understand the stents market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the stent industry.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Stents Market Research 2020: Forecasts by Product (Peripheral, Coronary), by Peripheral Stents Type (Iliac Stents, Femoral-Popliteal Stents, Renal Stents, Carotid Stents, Neurovascular Stents, Gastrointestinal), by Coronary Stents Type (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents), by Material (Metal, Polymers, Biomaterials), by End-user (Hospitals, Cardiac Centers), by Type (Balloon-Expandable Stents, Self-Expandable Stents). Plus Analysis of Leading Companies and Countries. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Stents Market Report 2020-2030

    Download sample pages

    Complete the form below to download your free sample pages for Stents Market Report 2020-2030

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ